Mechanistically modeling peripheral cytokine dynamics following bispecific dosing in solid tumors
Abstract Bispecific antibodies exhibit proven clinical benefit, and many bispecifics are currently in clinical development for oncology. Cytokine release syndrome (CRS) is a common clinical adverse effect observed following CD3‐based bispecific dosing. However, the pathophysiology of CRS is not full...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Livro |
Publicado em: |
Wiley,
2023-11-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Número de Chamada: |
A1234.567 |
---|---|
Cópia 1 | Disponível |